About Biomensio
Biomensio is a company based in Tampere (Finland) founded in 2015. Biomensio has raised $2.65 million across 3 funding rounds from investors including European Union, Business Finland and EIC Fund. Biomensio offers products and services including Handheld Reader and Fluidic Cartridge. Biomensio operates in a competitive market with competitors including Biological Dynamics, Miroculus, DermaSensor, Achira and Zerigo Health, among others.
- Headquarter Tampere, Finland
-
Sectors
TechnologyHealthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Biomensio Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.65 M (USD)
in 3 rounds
-
Latest Funding Round
$55.68 K (USD), Grant
Mar 31, 2022
-
Investors
European Union
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biomensio
Biomensio offers a comprehensive portfolio of products and services, including Handheld Reader and Fluidic Cartridge.
Portable tool for rapid multianalyte detection from samples.
Component for loading and processing samples in biosensing tests.
People of Biomensio
Unlock access to complete
Unlock access to complete
Funding Insights of Biomensio
Biomensio has successfully raised a total of $2.65M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $55.68 thousand completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biomensio
Biomensio has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, Business Finland and EIC Fund.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Innovative business solutions are provided by Siemens Technology Accelerator.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Biomensio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biomensio
Investment portfolio details for Biomensio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biomensio
Detailed financials for Biomensio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biomensio Comparisons
Peer comparison for Biomensio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biomensio
Biomensio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biological Dynamics, Miroculus, DermaSensor, Achira and Zerigo Health, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
|
| Locked | Locked | Locked |
MicroRNA profiling platform is developed to detect genes in samples.
|
|
| Locked | Locked | Locked |
Handheld diagnostic device for skin cancer lesions is developed.
|
|
| Locked | Locked | Locked |
Provider of diagnostic medical devices for screening Covid 19
|
|
| Locked | Locked | Locked |
Developer of UVB light therapy devices for monitoring Psoriasis, Vitiligo, and Eczema
|
|
| Locked | Locked | Locked |
Microfluidic-based technology is developed for monodisperse capsules and emulsions.
|
Detailed competitors of Biomensio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biomensio
Complete news archive for Biomensio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biomensio
Biomensio was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Biomensio is headquartered in Tampere, Finland.
Biomensio is a funded company, having raised a total of $2.65M across 3 funding rounds to date.
Biomensio was founded in 2015 in Tampere, Finland, as a provider of cloud-based biosensors within the biotechnology sector. A lab-on-chip platform has been developed for detecting multiple analytes, utilizing a proprietary mass-sensitive micro-array based on film-bulk acoustic resonance technology integrated with application-specific circuits. Compatibility is ensured with samples such as saliva, blood, and food, enabling detection of proteins and nucleic acids for diagnostic purposes.
Biomensio's top competitors include DermaSensor, Biological Dynamics and Achira.
Biomensio offers Handheld Reader and Fluidic Cartridge.
Biomensio has 5 investors. Key investors include European Union, Business Finland, EIC Fund, Siemens Technology Accelerator, and VTT Ventures.